Dr. John Tu, MD

NPI: 1508897083
Total Payments
$15,516
2024 Payments
$2,283
Companies
31
Transactions
382
Medicare Patients
999
Medicare Billing
$64,549

Payment Breakdown by Category

Food & Beverage$8,912 (57.4%)
Consulting$3,050 (19.7%)
Travel$2,384 (15.4%)
Research$1,122 (7.2%)
Education$36.49 (0.2%)
Gifts$11.00 (0.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,912 370 57.4%
Consulting Fee $3,050 3 19.7%
Travel and Lodging $2,384 3 15.4%
Unspecified $1,122 3 7.2%
Education $36.49 2 0.2%
Gift $11.00 1 0.1%

Payments by Type

General
$14,394
379 transactions
Research
$1,122
3 transactions

Top Paying Companies

Company Total Records Latest Year
Biofrontera Inc. $2,703 8 $0 (2024)
Perrigo Company plc $2,195 4 $0 (2017)
AbbVie Inc. $1,504 68 $0 (2023)
Novartis Pharmaceuticals Corporation $1,068 48 $0 (2020)
Biofrontera Bioscience GmbH $872.00 3 $0 (2022)
Bausch Health US, LLC $828.11 2 $0 (2018)
Almirall LLC $800.00 1 $0 (2021)
Janssen Biotech, Inc. $674.31 43 $0 (2021)
Regeneron Healthcare Solutions, Inc. $627.67 13 $0 (2020)
PFIZER INC. $500.15 27 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,283 4 Biofrontera Inc. ($2,252)
2023 $184.20 5 UCB, Inc. ($104.65)
2022 $1,025 5 Biofrontera Bioscience GmbH ($872.00)
2021 $842.38 4 Almirall LLC ($800.00)
2020 $515.35 19 Regeneron Healthcare Solutions, Inc. ($140.76)
2019 $2,537 92 AbbVie, Inc. ($565.84)
2018 $3,110 110 Bausch Health US, LLC ($828.11)
2017 $5,019 143 Perrigo Company plc ($2,195)

All Payment Transactions

382 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/27/2024 Biofrontera Inc. AMELUZ (Drug), BF-RhodoLED, XEPI Consulting Fee Cash or cash equivalent $750.00 General
Category: DERMATOLOGY
12/09/2024 Biofrontera Inc. AMELUZ (Drug), BF-RhodoLED, XEPI Food and Beverage Cash or cash equivalent $2.33 General
Category: DERMATOLOGY
06/14/2024 Biofrontera Inc. AMELUZ (Drug), BF-RhodoLED, XEPI Consulting Fee Cash or cash equivalent $1,500.00 General
Category: DERMATOLOGY
04/24/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $30.32 General
Category: Immunology
10/06/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $20.46 General
Category: FACIAL AESTHETICS
03/19/2023 Amgen Inc. AMJEVITA (Biological), Otezla Food and Beverage In-kind items and services $24.00 General
Category: Inflammation
03/19/2023 AbbVie Inc. SKYRIZI (Biological) Food and Beverage In-kind items and services $20.89 General
Category: IMMUNOLOGY
03/18/2023 UCB, Inc. Food and Beverage In-kind items and services $104.65 General
02/01/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $14.20 General
Category: Immunology
11/30/2022 Biofrontera Bioscience GmbH Ameluz (Drug), BF-RhodoLED XL Food and Beverage Cash or cash equivalent $472.00 General
Category: Dermatology
11/30/2022 Biofrontera Bioscience GmbH Ameluz (Drug), BF-RhodoLED XL Travel and Lodging Cash or cash equivalent $389.00 General
Category: Dermatology
11/19/2022 Biofrontera Bioscience GmbH Ameluz (Drug), BF-RhodoLED XL Gift Cash or cash equivalent $11.00 General
Category: Dermatology
03/26/2022 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $44.86 General
03/25/2022 Biofrontera Inc. AMELUZ (Drug), BF-RhodoLED, XEPI Food and Beverage Cash or cash equivalent $108.19 General
Category: DERMATOLOGY
10/27/2021 Allergan, Inc. Food and Beverage In-kind items and services $15.16 General
06/23/2021 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $15.14 General
Category: Immunology
03/24/2021 Almirall LLC Klisyri (Drug) Consulting Fee Cash or cash equivalent $800.00 General
Category: Dermatology
02/26/2021 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $12.08 General
Category: Immunology
08/26/2020 Allergan, Inc. Food and Beverage In-kind items and services $14.12 General
08/05/2020 Janssen Biotech, Inc. REMICADE (Biological), STELARA, SIMPONI Food and Beverage In-kind items and services $13.74 General
Category: Immunology
03/17/2020 Ortho Dermatologics, a division of Bausch Health US, LLC SILIQ (Drug), DUOBRII Food and Beverage In-kind items and services $11.83 General
Category: DERMATOLOGY
03/11/2020 AbbVie Inc. SKYRIZI (Biological), HUMIRA Food and Beverage In-kind items and services $16.97 General
Category: IMMUNOLOGY
03/05/2020 Janssen Scientific Affairs, LLC TREMFYA (Drug) Food and Beverage In-kind items and services $112.13 General
Category: Immunology
03/04/2020 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $12.02 General
Category: Immunology
02/21/2020 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $122.12 General
Category: INFLAMMATION AND IMMUNOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris Bausch Health US, LLC $828.11 2
A randomized, double blind, vehicle-co ntrolled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz) and BF-RhodoLED in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). Biofrontera Inc. $293.39 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 214 324 $45,199 $15,217
2022 9 220 259 $49,002 $15,719
2021 9 289 409 $55,111 $17,593
2020 9 276 371 $50,524 $16,020
Total Patients
999
Total Services
1,363
Medicare Billing
$64,549
Procedure Codes
34

All Medicare Procedures & Services

34 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 79 104 $18,258 $6,182 33.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 27 31 $7,700 $2,666 34.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 31 31 $6,731 $2,224 33.0%
11102 Biopsy of related skin growth, first growth Office 2023 24 29 $5,726 $1,901 33.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 24 26 $2,850 $1,076 37.8%
17000 Destruction of precancer skin growth, 1 growth Office 2023 18 22 $2,878 $794.95 27.6%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 11 81 $1,056 $373.47 35.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 80 105 $18,738 $6,060 32.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 33 33 $7,262 $2,291 31.6%
11102 Biopsy of related skin growth, first growth Office 2022 21 28 $5,675 $1,825 32.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 11 11 $3,615 $1,281 35.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 13 14 $3,530 $1,195 33.9%
17110 Destruction of skin growth, 1-14 growths Office 2022 13 15 $3,357 $1,048 31.2%
17000 Destruction of precancer skin growth, 1 growth Office 2022 20 23 $3,047 $886.68 29.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 15 16 $1,775 $569.26 32.1%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 14 14 $2,003 $562.61 28.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 100 129 $23,140 $7,471 32.3%
11102 Tangential biopsy of single skin lesion Office 2021 38 40 $8,207 $2,325 28.3%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 28 28 $6,165 $1,846 29.9%
17110 Destruction of up to 14 skin growths Office 2021 13 15 $3,349 $1,340 40.0%
11104 Punch biopsy of single skin lesion Office 2021 12 13 $3,329 $1,312 39.4%
17000 Destruction of skin growth Office 2021 36 38 $4,941 $1,230 24.9%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 26 28 $3,083 $1,013 32.9%
11103 Tangential biopsy of additional skin lesion Office 2021 14 15 $1,567 $539.62 34.4%
17003 Destruction of 2-14 skin growths Office 2021 22 103 $1,329 $516.30 38.8%

About Dr. John Tu, MD

Dr. John Tu, MD is a Dermatology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508897083.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Tu, MD has received a total of $15,516 in payments from pharmaceutical and medical device companies, with $2,283 received in 2024. These payments were reported across 382 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($8,912).

As a Medicare-enrolled provider, Tu has provided services to 999 Medicare beneficiaries, totaling 1,363 services with total Medicare billing of $64,549. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Location Rochester, NY
  • Active Since 07/05/2006
  • Last Updated 12/02/2010
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1508897083

Products in Payments

  • AMELUZ (Drug) $2,703
  • Humira (Biological) $1,082
  • COSENTYX (Biological) $956.52
  • Ameluz (Drug) $872.00
  • Klisyri (Drug) $800.00
  • EUCRISA (Drug) $497.03
  • Otezla (Drug) $488.76
  • DUPIXENT (Biological) $455.39
  • TALTZ (Drug) $349.21
  • Tremfya (Drug) $312.49
  • Levulan (Drug) $289.26
  • Enbrel (Biological) $272.25
  • ILUMYA (Biological) $199.21
  • DUPIXENT DUPILUMAB INJECTION (Biological) $186.48
  • REMICADE (Biological) $177.09
  • KERYDIN (Drug) $170.88
  • Skyrizi (Biological) $153.91
  • TREMFYA (Drug) $153.56
  • ACZONE (Drug) $149.16
  • SILIQ (Drug) $132.20

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Rochester